Affymetrix, Inc. · Santa Clara, CA United States ·(NASDAQ (GS): AFFX)

Affymetrix detects the secrets of human genetics. Its GeneChip system and other products are used to identify, analyze, and manage genetic data in the development of new treatments for infectious diseases, cancer, and other ailments. Affymetrix sells its products directly to drugmakers, academic research labs, and government agencies in its key North American and European markets. It has partnerships with such companies as Roche and Johnson & Johnson subsidiary Veridex to develop disease diagnostics using its GeneChip technology. The company owns about 20% of Perlegen Sciences, which uses Affymetrix's technology to map genetic variations and tie them to human health for drug development. To read the full description, subscribe now.